Solen Therapeutics Files Q1 2025 10-Q
Ticker: SLNO · Form: 10-Q · Filed: 2025-05-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
Related Tickers: SLNO
TL;DR
Solen Therapeutics (SLNO) filed its Q1 2025 10-Q. Check financials.
AI Summary
Solen Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Capnia, Inc., is involved in electromedical and electrotherapeutic apparatus. Key financial details and operational updates for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational status of Solen Therapeutics, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a publicly traded company filing a 10-Q, there are inherent risks associated with financial performance and market conditions.
Key Players & Entities
- SOLENO THERAPEUTICS INC (company) — Filer
- Capnia, Inc. (company) — Former company name
- 20250331 (date) — Reporting period end date
- 20250507 (date) — Filing date
- REDWOOD CITY, CA (location) — Business address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the first quarter of 2025.
When was this 10-Q filed with the SEC?
The filing date is 20250507.
What was Solen Therapeutics Inc. formerly known as?
The company was formerly known as Capnia, Inc., with a date of name change on 20100219.
What is the Standard Industrial Classification (SIC) code for Solen Therapeutics Inc.?
The SIC code is 3845, categorized under ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
What is the business address of Solen Therapeutics Inc.?
The business address is 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
From the Filing
0000950170-25-065675.txt : 20250507 0000950170-25-065675.hdr.sgml : 20250507 20250507161345 ACCESSION NUMBER: 0000950170-25-065675 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250507 DATE AS OF CHANGE: 20250507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36593 FILM NUMBER: 25921521 BUSINESS ADDRESS: STREET 1: 100 MARINE PARKWAY, SUITE 400 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 100 MARINE PARKWAY, SUITE 400 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Capnia, Inc. DATE OF NAME CHANGE: 20100219 10-Q 1 slno-20250331.htm 10-Q 10-Q Q1 365 days false 0001484565 --12-31 365 days 365 days SOLENO THERAPEUTICS INC http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent http://fasb.org/srt/2024#ChiefExecutiveOfficerMember 0001484565 srt:MaximumMember 2025-01-01 2025-03-31 0001484565 slno:UnderwriterMember 2024-01-01 2024-03-31 0001484565 slno:TwoThousandTwentyInducementEquityIncentivePlanMember 2024-01-24 0001484565 us-gaap:CommonStockMember us-gaap:EmployeeStockOptionMember us-gaap:SubsequentEventMember 2025-04-01 2025-04-01 0001484565 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001484565 us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001484565 slno:TwoThousandAndFourteenEquityIncentivePlanMember srt:MinimumMember us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001484565 slno:ConsultantMember 2025-01-01 2025-03-31 0001484565 slno:UnderwrittenPublicOfferingMember 2023-10-02 0001484565 us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:SubsequentEventMember 2025-04-01 2025-04-30 0001484565 slno:UnderwrittenPublicOfferingMember slno:SecuritiesPurchaseAgreementMember srt:MaximumMember 2022-01-01 2022-12-31 0001484565 slno:CorporateDebtSecuritiesAndCommercialPaperMember 2025-03-31 0001484565 slno:KristenYenMember 2025-01-01 2025-03-31 0001484565 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001484565 us-gaap:CommonStockMember 2023-12-31 0001484565 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001484565 slno:TwoThousandAndFourteenEquityIncentivePlanMember us-gaap:EmployeeStockOptionMember 2024-01-17 0001484565 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001484565 2025-01-01 2025-03-31 0001484565 slno:AnishBhatnagarMember 2025-01-01 2025-03-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001484565 slno:OctoberTwoThousandTwentyThreePreFundedWarrantsMember 2024-12-31 0001484565 slno:TwoThousandAndFourteenEquityIncentivePlanMember us-gaap:EmployeeStockOptionMember 2025-03-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0001484565 srt:MinimumMember 2025-01-01 2025-03-31 0001484565 2024-01-01 2024-12-31 0001484565 slno:SecuritiesPurchaseAgreementMember 2022-12-16 0001484565 us-gaap:EmployeeStockOptionMember slno:TwoThousandAndFourteenEquityIncentivePlanAndTwoThousandTwentyInducementEquityIncentivePlanMember 2024-12-31 0001484565 slno:MayTwoThousandTwentyThreeTrancheBPreFundedExchangeWarrantsMember 2025-01-01 2025-03-31 0001484565 slno:LoanAndSecurityAgreementMember slno:OxfordFinancingLLCAndItsAffiliatesMember slno:FDAApprovalOFVYKATXRTrancheTwoMember 2025-01-01 2025-03-31 0001484565 slno:LoanAndSecurityAgreementMember slno:OxfordFinancingLLCAndItsAffiliatesMember slno:FivePercenta